Blunted humoral immune response to the fourth dose of BNT162b2 COVID-19 vaccine in patients undergoing hemodialysis.

Daisuke KanaiHiromichi WakuiMasaaki HanaokaTatsuya HazeKengo AzushimaSatoru ShinodaShunichiro TsukamotoShinya TaguchiSho KinguchiTomohiko KanaokaYoshiyuki ToyaNobuhito HirawaHideaki KatoFumimasa WatanabeKanako HanaokaHiroshi MitsuhashiSatoshi YamaguchiToshimasa OhnishiKouichi Tamura

Published in: Clinical and experimental nephrology (2023)

These findings suggest that the humoral immune response was blunted after the fourth dose of the conventional BNT162b2 vaccine. However, multiple vaccinations could extend the window of humoral immune protection.

Keyphrases

immune response
patients undergoing
coronavirus disease
dendritic cells
sars cov
toll like receptor
peritoneal dialysis